# Aardvark Therapeutics, Inc.: Form 8-K, filed Nov 6, 2025

- Company: [Aardvark Therapeutics, Inc.](/companies/aard.md) (CIK 1774857)
- Form: 8-K
- Filed: 2025-11-06
- Accepted by EDGAR: Nov 5, 2025, 18:11 ET
- Period: 2025-11-05
- Accession: 0001193125-25-267402
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1774857/000119312525267402/ck0001774857-20251105.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1774857/000119312525267402/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1774857/000119312525267402/ck0001774857-20251105.htm

Filed Nov 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-267402. Last ingested by Listed: Nov 14, 2026, 11:27 ET. No prices; not investment advice.
